NOX 0.00% 10.0¢ noxopharm limited

Ann: New Independent Trial Data Supports Potential of Veyonda, page-8

  1. 113 Posts.
    lightbulb Created with Sketch. 30
    Being so pessimistic now. Will prove to be expensive when acquisition takes place.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.